FIBRINOLYTIC THERAPY OF THROMBOEMBOLIC DISEASE.
D000347:Afibrinogenemia; D000906:Antibodies; D001777:Blood Coagulation; D001780:Blood Coagulation Tests; D003850:Deoxyribonuclease I; D004358:Drug Therapy; D005164:Factor IX; D005165:Factor V; D005169:Factor VIII; D005170:Factor X; D005340:Fibrinogen; D005341:Fibrinolysin; D006801:Humans; D007263:Infusions, Parenteral; D010958:Plasminogen; D011516:Prothrombin; D012106:Research; D013299:Streptodornase and Streptokinase; D013300:Streptokinase; D013923:Thromboembolism; D015912:Thrombolytic Therapy; D014116:Toxicology
D000906:Antibodies; C427184:recombinant factor VIII SQ; D005165:Factor V; D011516:Prothrombin; D005169:Factor VIII; D005164:Factor IX; D005170:Factor X; D005340:Fibrinogen; D010958:Plasminogen; D013299:Streptodornase and Streptokinase; D003850:Deoxyribonuclease I; D013300:Streptokinase; D005341:Fibrinolysin
AFIBRINOGENEMIA; ANTIBODIES; BLOOD COAGULATION; BLOOD COAGULATION TESTS; DRUG THERAPY; EXPERIMENTAL LAB STUDY; FACTOR IX; FACTOR V; FACTOR VIII; FACTOR X; FIBRINOGEN; FIBRINOLYSIN; INFUSIONS, PARENTERAL; PLASMINOGEN; PROTHROMBIN; STREPTODORNASE AND STREPTOKINASE; THROMBOEMBOLISM; TOXICOLOGIC REPORT